The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

Sarah Hummel, Wendy Kohlmann, Thomas M. Kollmeyer, Robert Brian Jenkins, Joshua Sonnen, Cheryl A. Palmer, Howard Colman, Diana Abbott, Lisa Cannon-Albright, Adam L. Cohen

Research output: Contribution to journalArticle

Abstract

Background: IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate cancer risk in related individuals. Methods: One hundred and two individuals with IDH1/2 mutant or 1p/19q co-deleted glioma were genotyped and linked to the UPDB. DNA came from blood (21), tumor tissue (43), or both (38). We determined congruence between somatic and germline samples and estimated the relative risk for developing cancer to first and second-degree relatives of G and A allele carriers at rs55705857. Results: Somatic (glioma) DNA had 85.7% sensitivity (CI 57.2-98.2%) and 95.8% specificity (CI 78.9-99.89%) for germline rs55705857 G allele. Forty-one patients were linked to pedigrees in the UPDB with at least three generations of data. First-degree relatives of rs55705857 G allele carriers were at significantly increased risk for developing cancer (RR = 1.72, p = 0.045, CI 1.02-2.94), and specifically for oligodendroglioma (RR = 57.61, p = 0.017, CI 2.96-320.98) or prostate cancer (RR = 4.10, p = 0.008, CI 1.62-9.58); relatives of individuals without the G allele were not at increased risk. Second-degree relatives of G allele carriers also had significantly increased risk for developing cancer (RR = 1.50, p = 0.007, CI 1.15-2.01). Conclusions: Tumor DNA may approximate genotype at the rs55705857 locus. We confirmed this locus confers an increased risk of all cancers and especially of oligodendroglioma. No increased cancer or brain tumor risk is seen in family members of individuals without the high-risk G allele.

Original languageEnglish (US)
Article number190
JournalBMC cancer
Volume19
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Alleles
Databases
Population
Neoplasms
Glioma
Oligodendroglioma
Brain Neoplasms
DNA
Genealogy and Heraldry
Pedigree
Prostatic Neoplasms
Genotype

Keywords

  • Cancer
  • IDH
  • Molecular epidemiology
  • Oligodendroglioma
  • rs55705857

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database. / Hummel, Sarah; Kohlmann, Wendy; Kollmeyer, Thomas M.; Jenkins, Robert Brian; Sonnen, Joshua; Palmer, Cheryl A.; Colman, Howard; Abbott, Diana; Cannon-Albright, Lisa; Cohen, Adam L.

In: BMC cancer, Vol. 19, No. 1, 190, 01.03.2019.

Research output: Contribution to journalArticle

Hummel, S, Kohlmann, W, Kollmeyer, TM, Jenkins, RB, Sonnen, J, Palmer, CA, Colman, H, Abbott, D, Cannon-Albright, L & Cohen, AL 2019, 'The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database', BMC cancer, vol. 19, no. 1, 190. https://doi.org/10.1186/s12885-019-5381-2
Hummel, Sarah ; Kohlmann, Wendy ; Kollmeyer, Thomas M. ; Jenkins, Robert Brian ; Sonnen, Joshua ; Palmer, Cheryl A. ; Colman, Howard ; Abbott, Diana ; Cannon-Albright, Lisa ; Cohen, Adam L. / The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database. In: BMC cancer. 2019 ; Vol. 19, No. 1.
@article{4dccb27fe2c241c9bfd9c63b4d305b5f,
title = "The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database",
abstract = "Background: IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate cancer risk in related individuals. Methods: One hundred and two individuals with IDH1/2 mutant or 1p/19q co-deleted glioma were genotyped and linked to the UPDB. DNA came from blood (21), tumor tissue (43), or both (38). We determined congruence between somatic and germline samples and estimated the relative risk for developing cancer to first and second-degree relatives of G and A allele carriers at rs55705857. Results: Somatic (glioma) DNA had 85.7{\%} sensitivity (CI 57.2-98.2{\%}) and 95.8{\%} specificity (CI 78.9-99.89{\%}) for germline rs55705857 G allele. Forty-one patients were linked to pedigrees in the UPDB with at least three generations of data. First-degree relatives of rs55705857 G allele carriers were at significantly increased risk for developing cancer (RR = 1.72, p = 0.045, CI 1.02-2.94), and specifically for oligodendroglioma (RR = 57.61, p = 0.017, CI 2.96-320.98) or prostate cancer (RR = 4.10, p = 0.008, CI 1.62-9.58); relatives of individuals without the G allele were not at increased risk. Second-degree relatives of G allele carriers also had significantly increased risk for developing cancer (RR = 1.50, p = 0.007, CI 1.15-2.01). Conclusions: Tumor DNA may approximate genotype at the rs55705857 locus. We confirmed this locus confers an increased risk of all cancers and especially of oligodendroglioma. No increased cancer or brain tumor risk is seen in family members of individuals without the high-risk G allele.",
keywords = "Cancer, IDH, Molecular epidemiology, Oligodendroglioma, rs55705857",
author = "Sarah Hummel and Wendy Kohlmann and Kollmeyer, {Thomas M.} and Jenkins, {Robert Brian} and Joshua Sonnen and Palmer, {Cheryl A.} and Howard Colman and Diana Abbott and Lisa Cannon-Albright and Cohen, {Adam L.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1186/s12885-019-5381-2",
language = "English (US)",
volume = "19",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

AU - Hummel, Sarah

AU - Kohlmann, Wendy

AU - Kollmeyer, Thomas M.

AU - Jenkins, Robert Brian

AU - Sonnen, Joshua

AU - Palmer, Cheryl A.

AU - Colman, Howard

AU - Abbott, Diana

AU - Cannon-Albright, Lisa

AU - Cohen, Adam L.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate cancer risk in related individuals. Methods: One hundred and two individuals with IDH1/2 mutant or 1p/19q co-deleted glioma were genotyped and linked to the UPDB. DNA came from blood (21), tumor tissue (43), or both (38). We determined congruence between somatic and germline samples and estimated the relative risk for developing cancer to first and second-degree relatives of G and A allele carriers at rs55705857. Results: Somatic (glioma) DNA had 85.7% sensitivity (CI 57.2-98.2%) and 95.8% specificity (CI 78.9-99.89%) for germline rs55705857 G allele. Forty-one patients were linked to pedigrees in the UPDB with at least three generations of data. First-degree relatives of rs55705857 G allele carriers were at significantly increased risk for developing cancer (RR = 1.72, p = 0.045, CI 1.02-2.94), and specifically for oligodendroglioma (RR = 57.61, p = 0.017, CI 2.96-320.98) or prostate cancer (RR = 4.10, p = 0.008, CI 1.62-9.58); relatives of individuals without the G allele were not at increased risk. Second-degree relatives of G allele carriers also had significantly increased risk for developing cancer (RR = 1.50, p = 0.007, CI 1.15-2.01). Conclusions: Tumor DNA may approximate genotype at the rs55705857 locus. We confirmed this locus confers an increased risk of all cancers and especially of oligodendroglioma. No increased cancer or brain tumor risk is seen in family members of individuals without the high-risk G allele.

AB - Background: IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate cancer risk in related individuals. Methods: One hundred and two individuals with IDH1/2 mutant or 1p/19q co-deleted glioma were genotyped and linked to the UPDB. DNA came from blood (21), tumor tissue (43), or both (38). We determined congruence between somatic and germline samples and estimated the relative risk for developing cancer to first and second-degree relatives of G and A allele carriers at rs55705857. Results: Somatic (glioma) DNA had 85.7% sensitivity (CI 57.2-98.2%) and 95.8% specificity (CI 78.9-99.89%) for germline rs55705857 G allele. Forty-one patients were linked to pedigrees in the UPDB with at least three generations of data. First-degree relatives of rs55705857 G allele carriers were at significantly increased risk for developing cancer (RR = 1.72, p = 0.045, CI 1.02-2.94), and specifically for oligodendroglioma (RR = 57.61, p = 0.017, CI 2.96-320.98) or prostate cancer (RR = 4.10, p = 0.008, CI 1.62-9.58); relatives of individuals without the G allele were not at increased risk. Second-degree relatives of G allele carriers also had significantly increased risk for developing cancer (RR = 1.50, p = 0.007, CI 1.15-2.01). Conclusions: Tumor DNA may approximate genotype at the rs55705857 locus. We confirmed this locus confers an increased risk of all cancers and especially of oligodendroglioma. No increased cancer or brain tumor risk is seen in family members of individuals without the high-risk G allele.

KW - Cancer

KW - IDH

KW - Molecular epidemiology

KW - Oligodendroglioma

KW - rs55705857

UR - http://www.scopus.com/inward/record.url?scp=85064527187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064527187&partnerID=8YFLogxK

U2 - 10.1186/s12885-019-5381-2

DO - 10.1186/s12885-019-5381-2

M3 - Article

VL - 19

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 190

ER -